Topical and systemic copper peptide exposure should not be treated the same
They are not meant to be used in place of expert medical advice, diagnosis, or care
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
Research chemical GHK-Cu occupies a legal gray area, particularly when used by consumers for injection
Melanie Avalon: No, and thank you for doing what you're doing because honestly, I remember when I first saw your book, whenever somebody has a book and they have a product line associated with it, I'm always a little bit suspicious
Le Selank It acts as a positive allosteric modulator of GABA-A receptors, increasing the affinity of the GABA binding site without directly binding to the benzodiazepine site
